Robert Lorette

Robert Lorette is Chief Licensing Officer and heads Hunterian’s business development efforts. He is President & CEO of Boston Life Science Advisors (BLSA). Prior to founding BLSA in 2009, Bob served as Chief Business Officer and Senior Vice President of Dynogen Pharmaceuticals, Inc., a clinical-stage drug development company. From 1999 to 2002, Bob was Senior Vice President of Corporate Development for Boston Healthcare Associates, Inc., a firm providing management consulting and business advisory services to companies in the life sciences industry. From 1996 to 1999, he was Vice President of Corporate Development for UroMed Corporation. Before joining UroMed, Bob held several legal and general management positions with Bausch & Lomb Incorporated, a global eye care company. Prior to Bausch & Lomb, he practiced corporate law at a private firm. Bob received his bachelor’s degree in economics from the College of the Holy Cross, his law degree from Syracuse University College of Law and his master’s in public administration from the Maxwell School of Syracuse University. He also attended the Program for Management Development at the Harvard Business School.